Pre-Cure
Tumor-on-a-Chip Platform & 3D Cell Culture Models for Drug De and Personalized Medicine in Oncology
StartupPre-Cure is a Jerusalem-based startup in the Health Tech & Life Sciences sector, established in 2023. Tumor-on-a-Chip Platform & 3D Cell Culture Models for Drug De and Personalized Medicine in Oncology. Pre-Cure was founded by Dan Simhon. The company has 1-10 employees. Core technologies: Biologicals.
The company follows a B2C business model. Product stage: Clinical Trial.
- StagePre-Seed
- ProductClinical Trial
- ModelB2C
- Employees1-10
- HQJerusalem
- Last RoundUndisclosed
Dan SimhonCEO
5 articles covered by sources including www.themarker.com,
jlm-biocity.org,
www.calcalistech.com,
www.space.gov.il.
What does Pre-Cure do?
Pre-Cure transforms cancer treatment selection powered by multifunctional tumor-on-a-chip technology. In Pre-cure “organ-on-a-chip” becomes “patient-on-a-chip” where the entire clinical journey is reflected to provide accurate individual therapy predictions.
Who founded Pre-Cure?
Pre-Cure was founded in 2023 by Dan Simhon (CEO).
What sector is Pre-Cure in?
Pre-Cure operates in Health Tech & Life Sciences, Pharma & Medical Biotechnology, Drugs Discovery & Development, with core technologies in Biologicals. Target customers: Healthcare & Life Sciences, Life Sciences, Pharmaceuticals.
Where is Pre-Cure located?
Pre-Cure is based in Kalman Ya'akov Man St, Jerusalem, Israel.